Cargando…
Long‐term proactive management of psoriasis with calcipotriol and betamethasone dipropionate foam: an Italian consensus through a combined nominal group technique and Delphi approach
BACKGROUND: Although long‐term management of psoriasis is paramount, this approach is challenging in clinical practice. In the recent PSO‐LONG trial, a fixed‐dose combination of betamethasone dipropionate (BD) and calcipotriol (Cal) foam applied twice a week on non‐consecutive days for 52 weeks (pro...
Ejemplares similares
-
Porocarcinoma From Preexisting Hidroacanthoma Simplex: Dermoscopic Findings
por: Maione, Vincenzo, et al.
Publicado: (2020) -
Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: An Expert Delphi Consensus Statement
por: Fargnoli, Maria Concetta, et al.
Publicado: (2023) -
Risankizumab shows high efficacy and maintenance in improvement of response until week 52
por: Mastorino, Luca, et al.
Publicado: (2022) -
Topical Pharmacotherapy for Actinic Keratoses in Older Adults
por: Calzavara-Pinton, Piergiacomo, et al.
Publicado: (2022) -
Topical Treatment for the Management of Mild-to-Moderate Psoriasis: A Critical Appraisal of the Current Literature
por: Fargnoli, Maria Concetta, et al.
Publicado: (2023)